Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors. - Hoots, W. K.; Ebbesen, L. S.; Konkle, B. A.; Auerswald, G. K.-H.; Roberts, H. R.; Weatherall, J.; Ferran, J.-M.; Ljung, R. C. R. (Haemophilia, 2008)